Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Assets Average (2019 - 2025)

IDEAYA Biosciences' Assets Average history spans 7 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Assets Average fell 2.94% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 2.94%, while the annual FY2025 figure was $1.1 billion, 25.94% up from the prior year.
  • Assets Average for Q4 2025 was $1.1 billion at IDEAYA Biosciences, up from $1.1 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.2 billion in Q4 2024 and bottomed at $312.2 million in Q1 2021.
  • The 5-year median for Assets Average is $488.2 million (2023), against an average of $666.8 million.
  • The largest annual shift saw Assets Average skyrocketed 190.68% in 2021 before it dropped 2.94% in 2025.
  • A 5-year view of Assets Average shows it stood at $390.4 million in 2021, then increased by 2.32% to $399.4 million in 2022, then soared by 47.99% to $591.1 million in 2023, then soared by 99.95% to $1.2 billion in 2024, then dropped by 2.94% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Assets Average are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025).